|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Optimal Usage of Fecal Calprotectin for Intestinal Diseases|
|Eun Soo Kim|
|Korean J Med. 2018;93(4):364-368. Published online 2018 August 1 DOI: https://doi.org/10.3904/kjm.2018.93.4.364|
Optimal Usage of Fecal Calprotectin for Intestinal Diseases
Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
Optimal cut-off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?
Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
Fecal calprotectin as a non-invasive biomarker for intestinal involvement of Behçet's disease
Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases
Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
|This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Med has participated in CrossRef Text and Data Mining service since September 11, 2015.|